CTLA4 and neoplasm: Interestingly, combined CTLA-4+ TILs and PD-L1+ in tumor cells showed better sensitivity for predicting prognosis of ICCs in terms of OS and cumulative recurrence than that of overexpression of either CTLA-4 or PD-L1 alone.